Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy

Mathias Lutz, Andrea Worschech, Miriam Alb, Sabine Gahn, Laura Bernhard, Michael Schwab, Stefanie Obermeier, Hermann Einsele, Ulrike Kämmerer, Peter Heuschmann, Erdwine Klinker, Christoph Otto, Stephan Mielke

Blood (2015) 125 (2): 261–272.

https://doi.org/10.1182/blood-2014-09-601302

Published: 2015

Journal Articles

Men Show Significantly Higher T Lymphocyte Mediated Immune Responses Against H-Y Than Multiparous Women: Results from a Cross-Sectional Analysis in 114 Volunteer Blood Donors and Implications for Immunotherapy

Mathias Lutz, MD, Andrea Worschech, PhD, Miriam Alb, PhD, Sabine Gahn, Laura Bernhard, Michael Schwab, MD, Stefanie Obermeier, Hermann Einsele, MD, Ulrike Kämmerer, PhD, Peter Heuschmann, MD, Erdwine Klinker, MD, Christoph Otto, PhD, Stephan Mielke, MD

Blood (2014) 124 (21): 3831.

https://doi.org/10.1182/blood.V124.21.3831.3831

Published: 2014

Journal Articles

Boost and Loss Of Immune Responses Against Tumor-Associated Antigens In The Course Of Pregnancy As a Model For Immunotherapy

Mathias Lutz, Medical Student, Miriam Alb, MSc, Andrea Worschech, PhD, Sabine Gahn, MLS, Laura Bernhard, MLS, Michael Schwab, MD, Hermann Einsele, MD, Ulrike Kämmerer, PhD, Peter Heuschmann, MD, Erdwine Klinker, MD, Christoph Otto, PhD, Stephan Mielke, MD

Blood (2013) 122 (21): 4505.

https://doi.org/10.1182/blood.V122.21.4505.4505

Published: 2013

Journal Articles

Immune Responses Against the Tumor-Associated Antigens WT1, MUC-1, PRAME and HER2/Neu in 114 Prospectively Screened Healthy Donors: Effects of Gender and Prior Pregnancy and Implications for Immunotherapy

Mathias Lutz, Andrea Worschech, PhD, Sabine Gahn, MLS, Laura Bernhard, MLS, Michael Schwab, MD, Hermann Einsele, MD, Ulrike Kämmerer, PhD, Peter Heuschmann, MD, Erdwine Klinker, MD, Christoph Otto, PhD, Stephan Mielke, MD

Blood (2012) 120 (21): 4115.

https://doi.org/10.1182/blood.V120.21.4115.4115

Published: 2012

Journal Articles

Comparison of 200 cGy vs. 400 cGy Total Body Irradiation (TBI) When Used with Fludarabine for Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RIC AHSCT).

Ronald Sobecks, Robert Dean, Lisa Rybicki, Josephine Chan, Karl Theil, Roger Macklis, Steve Andresen, Matt Kalaycio, Brad Pohlman, Christine Ferraro, Kelly Cherni, Laura Bernhard, John Sweetenham, Edward Copelan, Brian Bolwell

Blood (2007) 110 (11): 2003.

https://doi.org/10.1182/blood.V110.11.2003.2003

Published: 2007

Journal Articles

Non-Relapse Mortality Associated with Autologous Stem Cell Transplant (ASCT).

Christy Stotler, Matt Kalaycio, Robert M. Dean, Ronald Sobecks, Edward A. Copelan, Steven Andresen, Brad Pohlman, John William Sweetenham, Lisa Rybicki, Stacey Brown, Kim Bell, Kelly Cherni, Laura Bernhard, Christina Ferraro, Brian J. Bolwell

Blood (2007) 110 (11): 1671.

https://doi.org/10.1182/blood.V110.11.1671.1671

Published: 2007

Journal Articles

Comparison of T Cell (CD3+) Chimerism after Myeloablative (MY) and Nonmyeloablative (NM) Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).

Ronald Sobecks, MD, Karl Theil, MD, Lisa Rybicki, MS, Jennifer Bates, BS, Matt Kalaycio, MD, Steven Andresen, DO, Brad Pohlman, MD, Robert M. Dean, MD, John William Sweetenham, MD, Laura Bernhard, RN, Kelly Cherni, RN, Mary Serafin, RN, Karen Sands, RN, Jennifer Kosar, RN, Brian J. Bolwell, MD

Blood (2006) 108 (11): 2960.

https://doi.org/10.1182/blood.V108.11.2960.2960

Published: 2006

Journal Articles

Influence of Killer Immunoglobulin-Like Receptor (KIR) Matching on Achieving T Cell (CD3+) Complete Donor Chimerism (CDC) in Related Donor Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NMHSCT).

Ronald Sobecks, MD, Edward J. Ball, PhD, Medhat Askar, MD, PhD., Karl Theil, MD, Lisa Rybicki, MS, Dawn Thomas, CHS, Jennifer Bates, BS, Matt Kalaycio, MD, Steven Andresen, DO, Brad Pohlman, MD, Robert M. Dean, MD, John William Sweetenham, MD, Laura Bernhard, RN, Kelly Cherni, RN, Jaroslaw P. Maciejewski, MD, MS, Brian J. Bolwell, MD

Blood (2006) 108 (11): 3012.

https://doi.org/10.1182/blood.V108.11.3012.3012

Published: 2006

Journal Articles

Post-Transplant Education Group Increases Patient Knowledge and Confidence.

Jane Dabney, Laura Bernhard, Kelly Cherni, Jennifer Kosar, Mary Serafin, Linda McLellan, Michele Visnosky, Louise Loejos, Julie Curtis, Brian Bolwell

Blood (2006) 108 (11): 3325.

https://doi.org/10.1182/blood.V108.11.3325.3325

Published: 2006

Journal Articles

Patients Mobilizing Large Numbers of CD34+ Cells ("Super-Mobilizers") Have Improved Survival in Autologous Stem Cell Transplantation for Lymphoid Malignancies.

Brian J. Bolwell, MD, Brad Pohlman, MD, Lisa Rybicki, MS, Matt Kalaycio, MD, Ronald Sobecks, MD, Robert M. Dean, MD, Laura Bernhard, RN, Kelly Cherni, RN, Christina Ferraro, RN, Jenny Bates, Stacey Brown, John William Sweetenham, MD

Blood (2006) 108 (11): 3378.

https://doi.org/10.1182/blood.V108.11.3378.3378

Published: 2006

Journal Articles

Comparing Psychosocial Profiles and Outcomes between Patients Undergoing Myeloablative and Non-Myeloablative Allogeneic Transplants.

Linda McLellan, Larry W. Foster, Lisa Rybicki, Jane Dabney, Michele Visnosky, Sungren Sungren, Alison Vellani, Nicole Berry, Kelly Cherni, Laura Bernhard, Jennifer Kosar, Mary Serafin, Karen Sands, Christina Ferraro, Brian J. Bolwell

Blood (2006) 108 (11): 77.

https://doi.org/10.1182/blood.V108.11.77.77

Published: 2006

Journal Articles

Very High Hospital Admission Rate after Outpatient Non-Myeloablative Allogeneic Stem Cell Transplant Using Fludarabine and Low Dose TBI.

Brian Bolwell, MD, Lisa Rybicki, Matt Kalaycio, MD, Brad Pohlman, MD, Steven Andresen, DO, Stacey Brown, Elizabeth Kuczkowski, Jennifer Bates, Laura Bernhard, R.N., Kelly Cherni, R.N., Janet Baker, R.N., Ronald Sobecks, MD

Blood (2005) 106 (11): 3667.

https://doi.org/10.1182/blood.V106.11.3667.3667

Published: 2005

Journal Articles

Improved Post-Transplant Outcomes in Hematologic Malignancy Patients Undergoing Non-Myeloablative Hematopoietic Stem Cell Transplant (NMHSCT) Using a 400 cGy Total Body Irradiation (TBI) Dose with Fludarabine.

Ronald M. Sobecks, MD, Karl S. Theil, MD, Lisa Rybicki, Roger Macklis, MD, Brad Pohlman, MD, Steve Andresen, DO, Stacey Brown, Elizabeth Kuczkowski, Kelly Cherni, R.N., Janet Baker, R.N., Laura Bernhard, R.N., Matt Kalaycio, MD, Brian Bolwell, MD

Blood (2005) 106 (11): 3674.

https://doi.org/10.1182/blood.V106.11.3674.3674

Published: 2005

Journal Articles

Tandem Autologous Stem Cell Transplantation for Patients with Primary Progressive or Rapidly Relapsing Hodgkin’s Disease.

Brian Bolwell, MD, Brad Pohlman, MD, Ronald Sobecks, MD, Steven Andresen, DO, Lisa Rybicki, Stacey Brown, Elizabeth Kuczkowski, Jennifer Bates, Laura Bernhard, R.N., Kelly Cherni, R.N., Janet Baker, R.N., Matt Kalaycio, M.D.

Blood (2005) 106 (11): 5482.

https://doi.org/10.1182/blood.V106.11.5482.5482

Published: 2005

Journal Articles

A Psychosocial Assessment of Patients before and after Autologous Stem Cell Transplantation.

Brian J. Bolwell, M.D., Linda McLellan, LISW, Larry Foster, Ph.D, Jane Dabney, LISW, Erin Welsh, LISW, Elizabeth Kuczkowski, Julie Curtis, R.N., Kimberly Bell, R.N., Janet Baker, R.N., Laura Bernhard, R.N., Kelly Cherni, R.N., Lisa Rybicki, Mikkael A. Sekeres, M.D, M.S.

Blood (2004) 104 (11): 3152.

https://doi.org/10.1182/blood.V104.11.3152.3152

Published: 2004

Journal Articles

The Kinetics of Etoposide (VP-16) Peripheral Blood Progenitor Cell (PBPC) Mobilization.

Brian J. Bolwell, M.D., Elizabeth Kuczkowski, Lisa Rybicki, Brad Pohlman, M.D., Steven Andresen, D.O., Ronald Sobecks, M.D., Janet Baker, R.N., Kelly Cherni, R.N., Laura Bernhard, R.N., Alison Vellani, Nicole Berry, Shawnda Sungren, Leslie Foster, Matt Kalaycio, M.D.

Blood (2004) 104 (11): 4993.

https://doi.org/10.1182/blood.V104.11.4993.4993

Published: 2004

Journal Articles

High Dose Therapy with Autologous Blood Stem Cell Transplantation (Asct) for Relapsed, Follicular Lymphoma (FL) vs. De Novo, Diffuse Large B-Cell (dnDLBL) vs. Transformed, Follicular To Diffuse Large B-Cell Lymphoma (Tdlbl): No Difference in Freedom from Progression.

Brad Pohlman, M.D., Tony Jin, Kristie Summers, Elizabeth Kuczkowski, Stacey Brown, Matt Kalaycio, M.D., Ronald Sobecks, M.D., Steven Andresen, D.O., Laura Bernhard, R.N., Kelly Cherni, R.N., Janet Baker, R.N., Brian J. Bolwell, M.D.

Blood (2004) 104 (11): 1880.

https://doi.org/10.1182/blood.V104.11.1880.1880

Published: 2004

Journal Articles

The Prognostic Importance of Pre and Post Dendritic Cells in Autologous Transplantation for Diffuse Large B Cell Lymphoma.

Brian J. Bolwell, M.D., Brad Pohlman, M.D., Steve Andresen, D.O., Sheila Serafino, Ronald Sobecks, M.D., Elizabeth Kuczkowski, Julie Curtis, R.N., Lisa Rybicki, Jarek Maciejewski, M.D., PhD, Janet Baker, R.N., Kelly Cherni, R.N., Laura Bernhard, R.N., Matt Kalaycio, M.D., Eric Hsi, M.D., Karl Theil, M.D.

Blood (2004) 104 (11): 443.

https://doi.org/10.1182/blood.V104.11.443.443

Published: 2004

Journal Articles

High Dose Therapy with Autologous Blood Stem Cell Transplantation (ASCT) for Follicular Lymphoma: Long-Term Outcome According to Histologic Grade.

Brad Pohlman, M.D., Tony Jin, Kristie Summers, Elizabeth Kuczkowski, Matt Kalaycio, M.D., Ronald Sobecks, M.D., Steven Andresen, D.O., Laura Bernhard, R.N., Kelly Cherni, R.N., Janet Baker, R.N., Jennifer Bates, Brian J. Bolwell, M.D.

Blood (2004) 104 (11): 896.

https://doi.org/10.1182/blood.V104.11.896.896

Published: 2004

Journal Articles

Autologous Transplantation for Diffuse Large B Cell Lymphoma: Pre-Transplant Hypogammaglobulinemia Is a Predictor for Early Toxicities.

Brian J. Bolwell, M.D., Matt Kalaycio, M.D., Ronald Sobecks, M.D., Steven Andresen, D.O., Lisa Rybicki, Elizabeth Kuczkowski, Jennifer Bates, Kristie Summers, Laura Bernhard, Kelly Cherni, Janet Baker, Stacey Brown, Brad Pohlman, M.D.

Blood (2004) 104 (11): 908.

https://doi.org/10.1182/blood.V104.11.908.908

Published: 2004

NARROW

Boost and loss of immune responses against tumor-associated antigens in the course of pregnancy as a model for allogeneic immunotherapy

Men Show Significantly Higher T Lymphocyte Mediated Immune Responses Against H-Y Than Multiparous Women: Results from a Cross-Sectional Analysis in 114 Volunteer Blood Donors and Implications for Immunotherapy

Boost and Loss Of Immune Responses Against Tumor-Associated Antigens In The Course Of Pregnancy As a Model For Immunotherapy

Immune Responses Against the Tumor-Associated Antigens WT1, MUC-1, PRAME and HER2/Neu in 114 Prospectively Screened Healthy Donors: Effects of Gender and Prior Pregnancy and Implications for Immunotherapy

Comparison of 200 cGy vs. 400 cGy Total Body Irradiation (TBI) When Used with Fludarabine for Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RIC AHSCT).

Non-Relapse Mortality Associated with Autologous Stem Cell Transplant (ASCT).

Comparison of T Cell (CD3+) Chimerism after Myeloablative (MY) and Nonmyeloablative (NM) Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).

Influence of Killer Immunoglobulin-Like Receptor (KIR) Matching on Achieving T Cell (CD3+) Complete Donor Chimerism (CDC) in Related Donor Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NMHSCT).

Post-Transplant Education Group Increases Patient Knowledge and Confidence.

Patients Mobilizing Large Numbers of CD34+ Cells ("Super-Mobilizers") Have Improved Survival in Autologous Stem Cell Transplantation for Lymphoid Malignancies.

Comparing Psychosocial Profiles and Outcomes between Patients Undergoing Myeloablative and Non-Myeloablative Allogeneic Transplants.

Very High Hospital Admission Rate after Outpatient Non-Myeloablative Allogeneic Stem Cell Transplant Using Fludarabine and Low Dose TBI.

Improved Post-Transplant Outcomes in Hematologic Malignancy Patients Undergoing Non-Myeloablative Hematopoietic Stem Cell Transplant (NMHSCT) Using a 400 cGy Total Body Irradiation (TBI) Dose with Fludarabine.

Tandem Autologous Stem Cell Transplantation for Patients with Primary Progressive or Rapidly Relapsing Hodgkin’s Disease.

A Psychosocial Assessment of Patients before and after Autologous Stem Cell Transplantation.

The Kinetics of Etoposide (VP-16) Peripheral Blood Progenitor Cell (PBPC) Mobilization.

High Dose Therapy with Autologous Blood Stem Cell Transplantation (Asct) for Relapsed, Follicular Lymphoma (FL) vs. De Novo, Diffuse Large B-Cell (dnDLBL) vs. Transformed, Follicular To Diffuse Large B-Cell Lymphoma (Tdlbl): No Difference in Freedom from Progression.

The Prognostic Importance of Pre and Post Dendritic Cells in Autologous Transplantation for Diffuse Large B Cell Lymphoma.

High Dose Therapy with Autologous Blood Stem Cell Transplantation (ASCT) for Follicular Lymphoma: Long-Term Outcome According to Histologic Grade.

Autologous Transplantation for Diffuse Large B Cell Lymphoma: Pre-Transplant Hypogammaglobulinemia Is a Predictor for Early Toxicities.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only